Personal Information
Organization / Workplace
Greater New York City Area, NJ United States
Occupation
Global Business Leader In Life Science. Growth Strategies. Expert in Latin America.Trilingual Speaker. Capital Markets.
Industry
Medical / Health Care / Pharmaceuticals
About
Business Strategic Leader in Life Science.
Broad experience in pharmaceutical & biotech (e.g. oncology, hematology, rare diseases /orphan drugs), diagnostic / pharmacogenomics, consumer product, nutrition, personal care, medical devices, and chemical industries
Expertise in Global Business and Proficiency in Latin American Markets
Extensive experience in Consulting, General Management with P&L Responsibility, and Business Units Management at Corporate, Regional and Country level; creating, managing and leading the Strategic Planning, Business & Commercial Development, Geographical Expansion, Start ups, Alliances, Greenfield or Partnerships, Negotiation of Agreements, Change Management, ...
Tags
fernando ferrer mba
multinational partnerships
enfermedades raras
rare diseases
latin america
enfermedades poco frecuentes
orphan drugs
américa latina
legislation
brazil
dominican republic
republica dominicana
enfermedades huerfanas
enfermedades catastroficas
enfermedades complejas
amavi
brasil
drogas huerfanas
pacientes
cancer
expanding your life science business even further
latinamerica
adapa.org.do
asociaciones de pacientes
pharmaceutical industry
industria farmaceutica
medicamentos
legislación
abiad
food supplements
dietary supplements
anvisa
sobredosis
suplementos dietarios
sindusfarma
us market
abifisa
bacteria
probiotics
stability
overdose
estabilidad
national regulatory agency
fda
argentina
pharmaceutical
strategy
international business
patient advocacy groups in latin america
#sustainabledevelopmentgoals
#sdg3.8
#doencasraras
#amaviraras
#ourhealthadvocacy
#multinationalpartnerships
#fernandoferrermba
#brasil
#unitednations
#americalatina
#medicines
#orphandrugs
#rarediseases
hospital
hospital de especialidades pediátricas
medicos
hospital del niño
hepoth
panamá
market access
12 foro alianza latina
forum
ican
perla 2021
americas
usa
mexico
doenças raras
patients
enfermidades raras
regulatory convergence
convergence and harmonization
clinical trials
growth and expansion
regulatory affairs
hispanic
disruptive technologies
raps congress 2015
baltimore md
inclusion of communities
.
#políticas publicas
#enfermidadesraras
#saúde pública
#diagnóstico
#drogasórfãnas
#acessoecobertura
#metasdesenvolvimentosustentav
#resoluçãoonu
#assistência médica
#naçõesunidas
#highlevel-meeting
#diagnosis
#publichealth
#accessandcoverage
#latinamerica
#unresolution
#brazil
#healthcare
multinational partnerships llc
16 alianza latina
#législation
#legislacion
#latinomerica
#dominicanrepublic
#republicadominicana
#adapa.org.do
#asociacionesdepacientes
#pacientes
#pharmaceuticalindustry
#industriafarmaceutica
#medicamentos
#enfermedadescomplejas
#enfermedadescatastroficas
#enfermedadeshuerfanas
#enfermedadespocofrecuentes
#enfermedadesraras
salud
leyes
pompe
fabry
enfermedad de gaucher
mucopolisacaridosis
esclerosis multiple
medicamentos huérfanos
central america
south america
political environment
2025
2019
presidentila elections
presidents and head of government
venezuela
colombia
process
control
implementation
creation
any journey starts with a desire
trilingual
rvcc
business
international
ippc
global
strategic planning
abrale
regulations
congress
r&d
deputy
senator
12 forum alianza latina
rio de janeiro
alianza latina
growth strategies
centro de inmunología molecular cim
cencec
cecmed
raps
technology
embargo
consulting
zed mariel
cuba
cigb
rafael perez cristia
centro de ingeniería genética y biotecnologí
coordinador de ensayos clínicos
farmacéutica
medicina
latino america
medicamento
2021perla
diagnostico
drogas orfanas
industrial
farmaceuticas
biotechnology
biotech
doentes
2021 perla
pharmaceuticals
drugs
emerging and latin american markets
business expansion in global
See more
Presentations
(24)Documents
(3)Likes
(1)UN resolution on people with rare diseases Session 1 Oct 27 2023 PDF.pdf
Fernando Ferrer, MBA
•
6 months ago
Personal Information
Organization / Workplace
Greater New York City Area, NJ United States
Occupation
Global Business Leader In Life Science. Growth Strategies. Expert in Latin America.Trilingual Speaker. Capital Markets.
Industry
Medical / Health Care / Pharmaceuticals
About
Business Strategic Leader in Life Science.
Broad experience in pharmaceutical & biotech (e.g. oncology, hematology, rare diseases /orphan drugs), diagnostic / pharmacogenomics, consumer product, nutrition, personal care, medical devices, and chemical industries
Expertise in Global Business and Proficiency in Latin American Markets
Extensive experience in Consulting, General Management with P&L Responsibility, and Business Units Management at Corporate, Regional and Country level; creating, managing and leading the Strategic Planning, Business & Commercial Development, Geographical Expansion, Start ups, Alliances, Greenfield or Partnerships, Negotiation of Agreements, Change Management, ...
Tags
fernando ferrer mba
multinational partnerships
enfermedades raras
rare diseases
latin america
enfermedades poco frecuentes
orphan drugs
américa latina
legislation
brazil
dominican republic
republica dominicana
enfermedades huerfanas
enfermedades catastroficas
enfermedades complejas
amavi
brasil
drogas huerfanas
pacientes
cancer
expanding your life science business even further
latinamerica
adapa.org.do
asociaciones de pacientes
pharmaceutical industry
industria farmaceutica
medicamentos
legislación
abiad
food supplements
dietary supplements
anvisa
sobredosis
suplementos dietarios
sindusfarma
us market
abifisa
bacteria
probiotics
stability
overdose
estabilidad
national regulatory agency
fda
argentina
pharmaceutical
strategy
international business
patient advocacy groups in latin america
#sustainabledevelopmentgoals
#sdg3.8
#doencasraras
#amaviraras
#ourhealthadvocacy
#multinationalpartnerships
#fernandoferrermba
#brasil
#unitednations
#americalatina
#medicines
#orphandrugs
#rarediseases
hospital
hospital de especialidades pediátricas
medicos
hospital del niño
hepoth
panamá
market access
12 foro alianza latina
forum
ican
perla 2021
americas
usa
mexico
doenças raras
patients
enfermidades raras
regulatory convergence
convergence and harmonization
clinical trials
growth and expansion
regulatory affairs
hispanic
disruptive technologies
raps congress 2015
baltimore md
inclusion of communities
.
#políticas publicas
#enfermidadesraras
#saúde pública
#diagnóstico
#drogasórfãnas
#acessoecobertura
#metasdesenvolvimentosustentav
#resoluçãoonu
#assistência médica
#naçõesunidas
#highlevel-meeting
#diagnosis
#publichealth
#accessandcoverage
#latinamerica
#unresolution
#brazil
#healthcare
multinational partnerships llc
16 alianza latina
#législation
#legislacion
#latinomerica
#dominicanrepublic
#republicadominicana
#adapa.org.do
#asociacionesdepacientes
#pacientes
#pharmaceuticalindustry
#industriafarmaceutica
#medicamentos
#enfermedadescomplejas
#enfermedadescatastroficas
#enfermedadeshuerfanas
#enfermedadespocofrecuentes
#enfermedadesraras
salud
leyes
pompe
fabry
enfermedad de gaucher
mucopolisacaridosis
esclerosis multiple
medicamentos huérfanos
central america
south america
political environment
2025
2019
presidentila elections
presidents and head of government
venezuela
colombia
process
control
implementation
creation
any journey starts with a desire
trilingual
rvcc
business
international
ippc
global
strategic planning
abrale
regulations
congress
r&d
deputy
senator
12 forum alianza latina
rio de janeiro
alianza latina
growth strategies
centro de inmunología molecular cim
cencec
cecmed
raps
technology
embargo
consulting
zed mariel
cuba
cigb
rafael perez cristia
centro de ingeniería genética y biotecnologí
coordinador de ensayos clínicos
farmacéutica
medicina
latino america
medicamento
2021perla
diagnostico
drogas orfanas
industrial
farmaceuticas
biotechnology
biotech
doentes
2021 perla
pharmaceuticals
drugs
emerging and latin american markets
business expansion in global
See more